Optogenetic targeting of AII amacrine cells restores retinal computations performed by the inner retina
- PMID: 37868206
- PMCID: PMC10589896
- DOI: 10.1016/j.omtm.2023.09.003
Optogenetic targeting of AII amacrine cells restores retinal computations performed by the inner retina
Abstract
Most inherited retinal dystrophies display progressive photoreceptor cell degeneration leading to severe visual impairment. Optogenetic reactivation of inner retinal neurons is a promising avenue to restore vision in retinas having lost their photoreceptors. Expression of optogenetic proteins in surviving ganglion cells, the retinal output, allows them to take on the lost photoreceptive function. Nonetheless, this creates an exclusively ON retina by expression of depolarizing optogenetic proteins in all classes of ganglion cells, whereas a normal retina extracts several features from the visual scene, with different ganglion cells detecting light increase (ON) and light decrease (OFF). Refinement of this therapeutic strategy should thus aim at restoring these computations. Here we used a vector that targets gene expression to a specific interneuron of the retina called the AII amacrine cell. AII amacrine cells simultaneously activate the ON pathway and inhibit the OFF pathway. We show that the optogenetic stimulation of AII amacrine cells allows restoration of both ON and OFF responses in the retina, but also mediates other types of retinal processing such as sustained and transient responses. Targeting amacrine cells with optogenetics is thus a promising avenue to restore better retinal function and visual perception in patients suffering from retinal degeneration.
Keywords: gene therapy; optogenetics; retina; vision restoration.
© 2023 The Authors.
Conflict of interest statement
D.D. reports grants from Foundation Fighting Blindness, USA and European Research Council, during the conduct of the study; D.D. is a co-inventor on patent #9193956 (Adeno-associated virus virions with variant capsid and methods of use thereof), with royalties paid to Adverum Biotechnologies. D.D. also has personal financial interests in Tenpoint Tx. and SparingVision, outside the submitted work. D.D., H.K., O.M., F.T., and E.O. are inventors on pending patent applications on methods to target A2 amacrine cells related to this work.
Figures
![None](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10589896/bin/fx1.gif)
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10589896/bin/gr1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10589896/bin/gr2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10589896/bin/gr3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10589896/bin/gr4.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10589896/bin/gr5.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10589896/bin/gr6.gif)
Similar articles
-
Optogenetic Strategies for Vision Restoration.Adv Exp Med Biol. 2021;1293:545-555. doi: 10.1007/978-981-15-8763-4_38. Adv Exp Med Biol. 2021. PMID: 33398841 Review.
-
Photoreceptive Ganglion Cells Drive Circuits for Local Inhibition in the Mouse Retina.J Neurosci. 2021 Feb 17;41(7):1489-1504. doi: 10.1523/JNEUROSCI.0674-20.2020. Epub 2021 Jan 4. J Neurosci. 2021. PMID: 33397711 Free PMC article.
-
Selective synaptic connections in the retinal pathway for night vision.J Comp Neurol. 2019 Jan 1;527(1):117-132. doi: 10.1002/cne.24313. Epub 2017 Sep 15. J Comp Neurol. 2019. PMID: 28856684 Free PMC article.
-
Function and Circuitry of VIP+ Interneurons in the Mouse Retina.J Neurosci. 2015 Jul 29;35(30):10685-700. doi: 10.1523/JNEUROSCI.0222-15.2015. J Neurosci. 2015. PMID: 26224854 Free PMC article.
-
Intrinsic properties and functional circuitry of the AII amacrine cell.Vis Neurosci. 2012 Jan;29(1):51-60. doi: 10.1017/S0952523811000368. Vis Neurosci. 2012. PMID: 22310372 Free PMC article. Review.
Cited by
-
Retinal ganglion cell repopulation for vision restoration in optic neuropathy: a roadmap from the RReSTORe Consortium.Mol Neurodegener. 2023 Sep 21;18(1):64. doi: 10.1186/s13024-023-00655-y. Mol Neurodegener. 2023. PMID: 37735444 Free PMC article. Review.
-
High spatial resolution artificial vision inferred from the spiking output of retinal ganglion cells stimulated by optogenetic and electrical means.Front Cell Neurosci. 2022 Dec 9;16:1033738. doi: 10.3389/fncel.2022.1033738. eCollection 2022. Front Cell Neurosci. 2022. PMID: 36568888 Free PMC article.
References
-
- da Cruz L., Dorn J.D., Humayun M.S., Dagnelie G., Handa J., Barale P.-O., Sahel J.-A., Stanga P.E., Hafezi F., Safran A.B., et al. Five-year safety and performance results from the Argus II retinal prosthesis system clinical trial. Ophthalmology. 2016;123:2248–2254. doi: 10.1016/j.ophtha.2016.06.049. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous